Cytosorbents Crp (CTSO) — Financial Flexibility Index
Cytosorbents Crp (CTSO) has a Financial Flexibility Index of -0.12x as of December 2025. Free cash flow of $-4.76 Million (operating CF $-4.83 Million minus capex $62.88K) represents 0% of total liabilities ($38.28 Million). Also explore Cytosorbents Crp net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytosorbents Crp Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Cytosorbents Crp across 22 annual periods. Check Cytosorbents Crp PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cytosorbents Crp (2004–2025)
Year-by-year free cash flow to debt coverage for Cytosorbents Crp. For the full company profile including market capitalisation, see how much is Cytosorbents Crp worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-12.21 Million | $-12.38 Million | $38.28 Million | ▲ +18.2% |
| 2024 | -0.39x | $-14.14 Million | $-14.43 Million | $36.26 Million | ▲ +43.6% |
| 2023 | -0.69x | $-20.72 Million | $-21.66 Million | $29.99 Million | ▲ +11.6% |
| 2022 | -0.78x | $-21.78 Million | $-28.23 Million | $27.86 Million | ▼ -116.6% |
| 2021 | -0.36x | $-9.72 Million | $-14.01 Million | $26.94 Million | ▲ +1.6% |
| 2020 | -0.37x | $-3.94 Million | $-5.61 Million | $10.73 Million | ▲ +42.3% |
| 2019 | -0.64x | $-15.24 Million | $-16.76 Million | $23.96 Million | ▼ -7.9% |
| 2018 | -0.59x | $-9.32 Million | $-10.84 Million | $15.81 Million | ▼ -70.6% |
| 2017 | -0.35x | $-4.78 Million | $-6.46 Million | $13.84 Million | ▲ +42.7% |
| 2016 | -0.60x | $-6.14 Million | $-6.73 Million | $10.17 Million | ▲ +78.0% |
| 2015 | -2.75x | $-8.37 Million | $-9.01 Million | $3.04 Million | ▼ -96.8% |
| 2014 | -1.40x | $-6.29 Million | $-6.66 Million | $4.51 Million | ▼ -681.5% |
| 2013 | -0.18x | $-3.27 Million | $-3.49 Million | $18.31 Million | ▲ +25.2% |
| 2012 | -0.24x | $-3.58 Million | $-3.62 Million | $14.96 Million | ▲ +88.6% |
| 2011 | -2.09x | $-3.78 Million | $-3.83 Million | $1.80 Million | ▼ -107.9% |
| 2010 | -1.01x | $-2.31 Million | $-2.48 Million | $2.30 Million | ▲ +63.3% |
| 2009 | -2.74x | $-2.66 Million | $-2.67 Million | $970.76K | ▼ -20.2% |
| 2008 | -2.28x | $-2.34 Million | $-2.37 Million | $1.03 Million | ▲ +20.3% |
| 2007 | -2.86x | $-2.59 Million | $-2.63 Million | $906.87K | ▼ -11.2% |
| 2006 | -2.57x | $-2.78 Million | $-2.85 Million | $1.08 Million | ▼ -424.8% |
| 2005 | -0.49x | $-50.00K | $-50.00K | $101.97K | ▲ +11.7% |
| 2004 | -0.56x | $-50.00K | $-50.00K | $90.00K | — |